The International Osteoporosis Foundation today recognized six companies, charter members of the IOF Corporate Responsibility Program for Bone Health, who have shown outstanding leadership within their organizations by promoting good bone health to their staff.
Award certificates were presented to representatives from Eli Lilly, Merck & Co, GSK, Roche, Novartis and Kyphon during a meeting of the IOF Committee of Corporate Advisers in Porto, Portugal.
"IOF encourages all companies to become good corporate citizens in the field of bone health and we are delighted to applaud these companies for their adoption of the IOF Corporate Responsibility Program for Bone Health," noted IOF Chief Executive Officer Daniel Navid. "The companies who are being recognized today have made a commitment to fight osteoporosis, holding tailored education and bone health promotional activities amongst their staff, to increase awareness about the condition, its risk factors and what individuals can do to reduce the risk of fractures."
Other companies including Fonterra Brands, Tetra Pak, Arent Fox and Weber Shandwick, have also helped to promote good bone health to their staff through a variety of activities.
The IOF Corporate Responsibility Program for Bone Health suggests voluntary actions that a company can take, such as running bone-health education programs, providing bone-friendly food in the canteen, making exercise facilities available, and paying for diagnostic and treatments.
Click here for further details
Osteoporosis is one of the most serious chronic, non-communicable diseases, affecting one out of three women worldwide (more than breast cancer), and one out of five men (more than prostate cancer).
What the charter companies have to say about IOF Corporate Responsibility Program for Bone Health:
"The IOF Corporate Responsibility Program for Bone Health provides a great opportunity, not only to raise awareness among our employees regarding the disease, but also a great way for Eli Lilly to connect with patients' main needs."
Marcel Lechanteur, Executive Director, Osteoporosis Business Unit - U.S., Eli Lilly & Co.
"GlaxoSmithKline is proud to be a part of the IOF Corporate Responsibility Program for Bone Health. As part of our commitment to patients and physicians in the field of osteoporosis, we see this program as an important opportunity to raise awareness of this condition, and to support our employees in taking the necessary steps to protect their bone health."
Laure Thibaud, Vice President of External Affairs, Pharmaceuticals Europe, GSK
"Kyphon is committed to the fight against osteoporosis and is proud to be a part of the IOF Corporate Responsibility Program for Bone Health. Through company activities, including our health fairs, wellness programs and educational materials, our goals are to raise awareness about the consequences of this crippling disease among patients and our employees in order to improve bone health and access to innovative treatments for spinal fractures."
Karen D. Talmadge, Ph.D. Executive Vice President and Chief Science Officer, Kyphon Inc.
"Our corporate bone responsibility sends a strong message we care. The task now is to roll this out to the rest of our 60,000 employees worldwide."
Dick Clark, CEO, Merck & Co
"The IOF Corporate Responsibility Program for Bone Health and the IOF World Osteoporosis Day have been an excellent opportunity to generate interest and awareness among both patients and Novartis' employees. Osteoporosis represents a major burden of disease for society and the IOF Corporate Responsibility Program for Bone Health facilitated important discussions on how to tackle this significant problem of our society."
Stephan Korte, Director, Global Advocacy, Novartis
"The International Osteoporosis Foundation (IOF) Corporate Responsibility Programme for Bone Health provides Roche with an excellent opportunity to raise the awareness of bone health to all employees. Osteoporosis can severely impact patients' lives and the IOF is leading the way in motivating people to take action to prevent, diagnose and treat this debilitating condition."
Luke Miels, Business Director PBA - Primary Care, Roche
Osteoporosis, in which the bones become porous and break easily, is one of the world's most common and debilitating diseases. The result: pain, loss of movement, inability to perform daily chores, and in many cases, death. One out of three women over 50 will experience osteoporotic fractures, as will one out of five men1, 2, 3. Unfortunately, screening for people at risk is far from being a standard practice. Osteoporosis can, to a certain extent, be prevented, it can be easily diagnosed and effective treatments are available.
The International Osteoporosis Foundation (IOF) is the only worldwide organization dedicated to the fight against osteoporosis. It brings together scientists, physicians, patient societies and corporate partners. Working with its 175 member societies in 86 locations, and other healthcare-related organizations around the world, IOF encourages awareness and prevention, early detection and improved treatment of osteoporosis.
1. Melton U, Chrischilles EA, Cooper C et al. How many women have osteoporosis? Journal of Bone Mineral Research, 1992; 7:1005-10
2. Kanis JA et al. Long-term risk of osteoporotic fracture in Malmo. Osteoporosis International, 2000; 11:669-674
3. Melton LJ, et al. Bone density and fracture risk in men. JBMR. 1998; 13:No 12:1915
iofbonehealth
Комментариев нет:
Отправить комментарий